Skip to content
AI IntelligenceMay 9, 2026Primary Market
Article

Calidi Biotherapeutics, Inc. · Undisclosed · Unbekannt

Calidi Biotherapeutics filed an 8-K reporting entry into a material definitive agreement and unregistered sales of equity securities, indicating a potential capital raise.

AI-generated: summaries written by AI from the linked sources. How we use AI

AI-generatedSource: SEC EDGAR
01

Source Brief

Calidi Biotherapeutics filed an 8-K reporting entry into a material definitive agreement and unregistered sales of equity securities, indicating a potential capital raise.